DAY 2, 17th September 2020 (19:30 - 20:20)
Prof. Carolyn Lam
Senior Consultant, Department of Cardiology,
National Heart Centre Singapore (NHCS)
Director, Women’s Heart Health at NHCS
From prevention to treatment - A new perspective on management for T2DM & HF patients
Prof. Carolyn Lam is a Senior Consultant from the Department of Cardiology at the National Heart Centre Singapore (NHCS). She is also the Director of the Women’s Heart Health at NHCS.
Her clinical sub-specialty is heart failure, and she is recognized globally for her expertise in heart failure with preserved ejection fraction (HFpEF). She also has expertise in women’s cardiovascular disease, hemodynamics, echocardiography, biomarkers and research clinical trials. She started the first Heart Failure with Preserved Ejection Fraction Programme and Women’s Heart Health Clinic in Singapore.
On the research front, Prof. Lam is a Research EXCO member of the SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme; a Scientific Advisor to the Clinical Trials Coordinating Centre at SingHealth; an Affiliate Member of the SingHealth Duke-NUS Institute of Precision Medicine. She is also a Clinician Scientist and received the National Medical Research Council (NMRC) Clinician Scientist Award in 2010.
DAY 2, 17th September 2020 (20:20 – 21:05)
‘New Advances of Hyperkalaemia Management’ – Optimizing your Day-to-Day Heart Care
Dr. Adrian Cheong is a cardiologist who graduated from the University of Oxford and spent years working in the United Kingdom, including at the Royal Brompton and Harefield Hospitals. In Hong Kong, he worked at the Prince of Wales Hospital and the Chinese University of Hong Kong. His fellowship training was at Hospital Bichat Claude-Bernard, Paris, focusing on focusing on minimally invasive valve and structural heart interventions.
His areas of special interest are:
•Minimally invasive treatment of Valvular heart disease
•Complex coronary artery disease
Dr. Adrian Cheong
Specialist in Cardiology